| 2025-09-16 |
复牌提示：
2025-09-15 19:50:00 停牌，复牌日期 2025-09-17 00:00:01
|
| 2025-08-08 |
详情>>
股本变动：
变动后总股本4543.84万股
变动原因 ▼▲
- 原因：
- From March 31, 2025 to June 30, 2025
Exercise of stock options
Stock-based compensation expense
|
| 2025-08-08 |
详情>>
业绩披露：
2025年中报每股收益-0.19美元,归母净利润-843.6万美元,同比去年增长46.87%
|
| 2025-06-30 |
详情>>
内部人交易：
GILL DAVID N等共交易5笔
|
| 2025-05-30 |
股东大会：
将于2025-07-11召开股东大会
会议内容 ▼▲
- 1.To elect one Class I director, David N. Gill, to hold office until the 2028 annual meeting of stockholders or until his earlier death, resignation or removal.
2.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.
3.To approve a non-binding advisory vote on the compensation of the Company’s named executive officers as disclosed in the accompanying proxy statement (the “Proxy Statement”).
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof by or at the direction of our board of directors.
|
| 2025-05-13 |
详情>>
业绩披露：
2025年一季报每股收益-0.12美元,归母净利润-519.6万美元,同比去年增长21.62%
|
| 2025-05-13 |
财报披露：
美东时间 2025-05-13 盘前发布财报
|
| 2025-03-04 |
详情>>
业绩披露：
2024年年报每股收益-0.67美元,归母净利润-2966.6万美元,同比去年增长-38.45%
|
| 2024-11-08 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.52美元,归母净利润-2287.6万美元,同比去年增长-11.92%
|
| 2024-08-12 |
详情>>
业绩披露：
2024年中报每股收益-0.36美元,归母净利润-1587.8万美元,同比去年增长-25.1%
|
| 2024-05-07 |
详情>>
业绩披露：
2024年一季报每股收益-0.15美元,归母净利润-662.9万美元,同比去年增长-3.74%
|
| 2024-04-29 |
股东大会：
将于2024-06-11召开股东大会
会议内容 ▼▲
- 1.To elect three Class III directors, Michael Rossi, Thomas Gad and Johan Wedell-Wedellsborg, each to hold office until the 2027 annual meeting of stockholders or until his earlier death, resignation or removal.
2.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.
3.To approve a non-binding advisory vote on the compensation of the Company’s named executive officers as disclosed in these proxy materials.
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof by or at the direction of our board of directors.
|
| 2024-02-29 |
详情>>
业绩披露：
2023年年报每股收益-0.49美元,归母净利润-2142.7万美元,同比去年增长77.58%
|
| 2023-11-13 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.47美元,归母净利润-2043.9万美元,同比去年增长78.87%
|
| 2023-08-10 |
详情>>
业绩披露：
2023年中报每股收益-0.29美元,归母净利润-1269.2万美元,同比去年增长81.66%
|
| 2023-05-08 |
详情>>
业绩披露：
2023年一季报每股收益-0.15美元,归母净利润-639万美元,同比去年增长77.23%
|
| 2023-04-28 |
股东大会：
将于2023-06-08召开股东大会
会议内容 ▼▲
- 1.To elect three (3) Class II directors, James I. Healy, M.D., Ashutosh Tyagi, M.D. and Laura J. Hamill each to hold office until the 2026 annual meeting of stockholders or until his or her earlier death, resignation or removal.
2.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.
3.To approve a non-binding advisory vote on the compensation of the Company’s named executive officers as disclosed in these proxy materials.
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2022-04-29 |
股东大会：
将于2022-06-09召开股东大会
会议内容 ▼▲
- 1.To elect two (2) Class I directors, Dr. Gérard Ber and David N. Gill, each nominated by our Board of Directors to serve for a three (3) year term to expire at the 2025 annual meeting of stockholders, each such nominee to hold office until his successor has been duly elected and qualified or until his earlier death, resignation or removal;
2.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.To approve a non-binding advisory vote on the compensation of the Company’s named executive officers as disclosed in these proxy materials;
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-28 |
股东大会：
将于2021-06-10召开股东大会
会议内容 ▼▲
- 1.To elect three (3) Class III directors, Thomas Gad, Claus Juan Meller-San Pedro, M.D., PhD., and Johan Wedell-Wedellsborg, each nominated by our Board of Directors to serve for a three (3) year term to expire at the 2024 annual meeting of stockholders, each such nominee to hold office until his successor has been duly elected and qualified or until his earlier death, resignation or removal
2.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021;
3.To approve a non-binding advisory vote on the compensation of the Company’s named executive officers as disclosed in these proxy materials;
4.To approve a non-binding advisory vote on the frequency of future advisory votes on the compensation of the Company’s named executive officers;
5.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2020-04-28 |
股东大会：
将于2020-06-11召开股东大会
会议内容 ▼▲
- 1.To elect three (3) Class II directors, James I. Healy, M.D., Ashutosh Tyagi, M.D., and Laura J. Hamill, nominated by our Board of Directors, each to serve for a three-year term to expire at the 2023 annual meeting of stockholders, each such nominee to hold office until his/her successor has been duly elected and qualified or until his/her earlier death, resignation or removal.
2.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020;
3.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2019-04-30 |
股东大会：
将于2019-06-06召开股东大会
会议内容 ▼▲
- 1.To elect two (2) Class I directors, Dr. Gérard Ber and David N. Gill, nominated by our Board of Directors, each to serve for a three-year term to expire at the 2022 annual meeting of stockholders and one (1) Class II director, Ashutosh Tyagi, M.D., nominated by our Board of Directors, to serve for a one-year term to expire at the 2020 annual meeting of stockholders, each such nominee to hold office until his successor has been duly elected and qualified or until his earlier death, resignation or removal.
2.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ended December 31, 2019.
3.To transact other business that may properly come before the Annual Meeting or any adjournment or postponement thereof.
|